Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.
Yahoo
Monday, February 13, 2012 - 10:26am
tags:
Inhibitex, Bristol-Myers Squibb, M&A
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Monday, February 13, 2012 - 10:25am
tags:
Vertex, hepatitis C, Gilead
Expecting Gilead To Break $70, Outperforming Merck
Seeking Alpha
Sunday, February 12, 2012 - 11:57am
tags:
Gilead Sciences, Merck
BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program
Pipeline Review
Sunday, February 12, 2012 - 11:55am
tags:
BioSante, LibiGel, female sexual dysfunction
China Biotech Week in Review: Fosun Pharma Plans Large Hong Kong IPO
Seeking Alpha
Sunday, February 12, 2012 - 11:34am
tags:
Fosun Pharmaceutical, Shanghai Pharmaceutical, Shanghai Biochip, Changchun BCHT Biotechnology, Nanjing Pharmaceutical, Takeda
Shantha to ramp up capacity
Business Standard, India
Sunday, February 12, 2012 - 11:31am
tags:
Shantha Biotech, Sanofi
Johnson & Johnson: A Reliable Dividend Growth Stock
Seeking Alpha
Sunday, February 12, 2012 - 11:30am
tags:
JNJ
Aurobindo Pharma declares 'hidden' income
Times of India, India
Sunday, February 12, 2012 - 11:25am
tags:
Aurobindo
Amgen To Near $100, Outperforming Pfizer
Seeking Alpha
Sunday, February 12, 2012 - 11:23am
tags:
Pfizer, Amgen
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution
Bradenton Herald, FL
Saturday, February 11, 2012 - 1:51pm
tags:
Xopenex, Sunovion, Mylan
Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Bradenton Herald, FL
Saturday, February 11, 2012 - 12:54pm
tags:
BioSante
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Web Inquirer, UK
Saturday, February 11, 2012 - 12:52pm
tags:
Biomarin
Dava Pharmaceuticals Pays $11 Million to Settle False Claims Act Allegations
Industry Week
Saturday, February 11, 2012 - 12:50pm
tags:
Dava Pharmaceuticals
How a NASA Discovery Could Launch a Coup in the Pharmaceutical Industry
Wall St Daily
Saturday, February 11, 2012 - 12:48pm
tags:
drug delivery
Vernalis shares rise 28% after US cold medicine deal
Guardian, UK
Saturday, February 11, 2012 - 12:46pm
tags:
Vernalis, Tris Pharma
GSK, Takeda say nay to in-house diagnostics units
FiercePharma
Saturday, February 11, 2012 - 12:42pm
tags:
GSK, Takeda
KV Pharmaceutical’s Q4 loss more than 7 times revenue
bizjournals.com
Saturday, February 11, 2012 - 12:37pm
tags:
KV Pharmaceutical
Watson Settles Patent Dispute
Yahoo/Zacks
Saturday, February 11, 2012 - 12:36pm
tags:
Watson Pharmaceuticals
Abbott Labs Offers Long, Solid Dividend History
Investors.com
Saturday, February 11, 2012 - 12:35pm
tags:
Abbott Laboratories
Incyte in Neutral Lane
Yahoo/Zacks
Saturday, February 11, 2012 - 12:33pm
tags:
Incyte

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.